Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rei Umezawa

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
Esophagus : Official Journal of the Japan Esophageal Society|June 29, 2018
Impact of change in serum albumin level during and after chemoradiotherapy in patients with locally advanced esophageal cancerKazuya Takeda, Rei Umezawa, Noriyoshi Takahashi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2017
Whole-body total lesion glycolysis is an independent predictor in patients with esophageal cancer treated with definitive chemoradiotherapyNoriyoshi Takahashi, Rei Umezawa, Kentaro Takanami, et al.
Frontiers in Oncology|May 24, 2021
The Long-Term Recovery of Parotid Glands in Nasopharyngeal Carcinoma Treated by Intensity-Modulated RadiotherapyShun Tasaka, Keiichi Jingu, Noriyoshi Takahashi, et al.
Journal of Radiation Research|June 12, 2023
Clinical impact of radiation-induced myocardial damage detected by cardiac magnetic resonance imaging and dose-volume histogram parameters of the left ventricle as prognostic factors of cardiac events after chemoradiotherapy for esophageal cancerRei Umezawa, Hideki Ota, Hidenobu Takagi, et al.
The Tohoku Journal of Experimental Medicine|December 16, 2021
The Impact of Histological Subtype on Survival Outcome of Patients with Stage IIB-IVA Cervical Cancer Who Received Definitive RadiotherapyShuko Miyahara, Keita Tsuji, Muneaki Shimada, et al.
European Radiology|May 5, 2018
Oesophageal squamous cell carcinoma: histogram-derived ADC parameters are not predictive of tumour response to chemoradiotherapyMaiko Kozumi, Hideki Ota, Takaya Yamamoto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 12, 2016
Evaluation of four-dimensional computed tomography (4D-CT)-based pulmonary ventilation: The high correlation between 4D-CT ventilation and (81m)Kr-planar images was foundTakayuki Kanai, Noriyuki Kadoya, Kengo Ito, et al.
Japanese Journal of Radiology|January 23, 2021
Differences in patterns of recurrence of squamous cell carcinoma and adenocarcinoma after radiotherapy for stage III non-small cell lung cancerYu Katagiri, Keiichi Jingu, Takaya Yamamoto, et al.
International Journal of Radiation Oncology, Biology, Physics|April 2, 2014
Evaluation of on-board kV cone beam computed tomography-based dose calculation with deformable image registration using Hounsfield unit modificationsYusuke Onozato, Noriyuki Kadoya, Yukio Fujita, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 15, 2023
Clinical impact of multimodal treatment including chemoradiotherapy, conversion surgery and postoperative chemotherapy for borderline resectable and unresectable locally advanced pancreatic cancer without disease progression after gemcitabine plus nab-paclitaxelRei Umezawa, Masamichi Mizuma, Kei Nakagawa, et al.
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Esophagus : Official Journal of the Japan Esophageal Society|June 29, 2018
Impact of change in serum albumin level during and after chemoradiotherapy in patients with locally advanced esophageal cancerKazuya Takeda, Rei Umezawa, Noriyoshi Takahashi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2017
Whole-body total lesion glycolysis is an independent predictor in patients with esophageal cancer treated with definitive chemoradiotherapyNoriyoshi Takahashi, Rei Umezawa, Kentaro Takanami, et al.
Frontiers in Oncology|May 24, 2021
The Long-Term Recovery of Parotid Glands in Nasopharyngeal Carcinoma Treated by Intensity-Modulated RadiotherapyShun Tasaka, Keiichi Jingu, Noriyoshi Takahashi, et al.
Journal of Radiation Research|June 12, 2023
Clinical impact of radiation-induced myocardial damage detected by cardiac magnetic resonance imaging and dose-volume histogram parameters of the left ventricle as prognostic factors of cardiac events after chemoradiotherapy for esophageal cancerRei Umezawa, Hideki Ota, Hidenobu Takagi, et al.
The Tohoku Journal of Experimental Medicine|December 16, 2021
The Impact of Histological Subtype on Survival Outcome of Patients with Stage IIB-IVA Cervical Cancer Who Received Definitive RadiotherapyShuko Miyahara, Keita Tsuji, Muneaki Shimada, et al.
European Radiology|May 5, 2018
Oesophageal squamous cell carcinoma: histogram-derived ADC parameters are not predictive of tumour response to chemoradiotherapyMaiko Kozumi, Hideki Ota, Takaya Yamamoto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 12, 2016
Evaluation of four-dimensional computed tomography (4D-CT)-based pulmonary ventilation: The high correlation between 4D-CT ventilation and (81m)Kr-planar images was foundTakayuki Kanai, Noriyuki Kadoya, Kengo Ito, et al.
Japanese Journal of Radiology|January 23, 2021
Differences in patterns of recurrence of squamous cell carcinoma and adenocarcinoma after radiotherapy for stage III non-small cell lung cancerYu Katagiri, Keiichi Jingu, Takaya Yamamoto, et al.
International Journal of Radiation Oncology, Biology, Physics|April 2, 2014
Evaluation of on-board kV cone beam computed tomography-based dose calculation with deformable image registration using Hounsfield unit modificationsYusuke Onozato, Noriyuki Kadoya, Yukio Fujita, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 15, 2023
Clinical impact of multimodal treatment including chemoradiotherapy, conversion surgery and postoperative chemotherapy for borderline resectable and unresectable locally advanced pancreatic cancer without disease progression after gemcitabine plus nab-paclitaxelRei Umezawa, Masamichi Mizuma, Kei Nakagawa, et al.
Pageof 14